vimarsana.com

Page 5 - நாட்டிலஸ் உயிரி தொழில்நுட்பவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome

Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sujal Patel-led Nautilus Biotechnology goes public as it tackles ambitious plan to analyze proteins

Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.